The move follows Arm’s recent foray into direct chip sales with the Meta deal, signaling a major shift in the data center processor landscape.

Arm Holdings offers significant upside with multi-year RPOs and strong partnerships. Read why ARM stock is a solid buy, ...

The rate of cGVHD-free survival was 78% at 1 year in patients who received Orca-T compared with 38% among patients who ...

During a live event, Catherine J. Lee, MD, MS, discussed the efficacy and safety results of various trials of approved agents ...

Results showed Orca’s treatment, a purified mix of donor-derived T cells and stem cells, was safer than standard transplant ...

Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...

Orca-T improved 1-year survival without severe graft-vs-host disease compared with standard transplant in the Precision-T ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Raised in Virginia by loving parents, mother, Dhy-Anne, and father, Morgan; brother, Geordan, and just a left arm, Baileigh ...

Darzalex and Revlimid maintenance resulted in superior outcomes versus Revlimid alone following autologous stem cell ...

KICKING off its 118th year in the country, Manulife Philippines — the local arm of the leading international financial services provider Manulife — has reaffirmed its commitment to adapting to rapidly ...